PubRank

Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders

Clinical Trial ID NCT00251303

PubWeight™ 5.35‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00251303

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994 8.82
2 Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther 2011 1.71
3 An open-label trial of riluzole in patients with treatment-resistant major depression. Am J Psychiatry 2004 1.71
4 An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression. Biol Psychiatry 2005 1.65
5 Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. Biol Psychiatry 2005 1.52
6 Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000 1.44
7 An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2007 1.10
8 A phase 1 trial of riluzole in spinal muscular atrophy. Arch Neurol 2003 1.00
9 Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder. Psychopharmacology (Berl) 2003 0.97
10 Glutamatergic drugs exacerbate symptomatic behavior in a transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder. Brain Res 2000 0.94
11 Children with obsessive-compulsive disorder: are they just "little adults"? J Clin Invest 2009 0.92
12 Stem cell therapy for autism. J Transl Med 2007 0.91
13 Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol 2006 0.87
14 Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998 0.81
Next 100